CIK 0001821825
- Large accelerated filer
Organon & Co.
Sign in to watch- Ticker
- OGN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 464838035
- Phone
- +1 551-430-6000
- Business address
- 30 HUDSON STREET, FL 33, JERSEY CITY, NJ, 07302
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Restricted Stock Units | +4,102 | 4,102 | ||
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Restricted Stock Units | +7,710 | 7,710 | ||
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Stock Option (Right to Buy) | +23,170 | 23,170 | ||
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Stock Option (Right to Buy) | +52,132 | 52,132 | ||
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Stock Option (Right to Buy) | +21,835 | 21,835 | ||
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Stock Option (Right to Buy) | +16,022 | 16,022 | ||
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Stock Option (Right to Buy) | +15,446 | 15,446 | ||
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Stock Option (Right to Buy) | +22,887 | 22,887 | ||
| 2021-06-02 | Ritter Geralyn S Hd of Ext. Affairs and ESG | Grant or award · Stock Option (Right to Buy) | +45,104 | 45,104 | ||
| 2021-06-02 | Telman Deborah H General Counsel | Grant or award · Restricted Stock Units | +19,337 | 19,337 | ||
| 2021-06-02 | Telman Deborah H General Counsel | Grant or award · Restricted Stock Units | +13,296 | 13,296 | ||
| 2021-06-02 | Telman Deborah H General Counsel | Grant or award · Restricted Stock Units | +17,624 | 17,624 | ||
| 2021-06-02 | Telman Deborah H General Counsel | Grant or award · Stock Option (Right to Buy) | +103,095 | 103,095 | ||
| 2021-06-02 | WALSH MATTHEW M Chief Financial Officer | Grant or award · Restricted Stock Units | +67,033 | 67,033 | ||
| 2021-06-02 | WALSH MATTHEW M Chief Financial Officer | Grant or award · Restricted Stock Units | +24,930 | 24,930 | ||
| 2021-06-02 | WALSH MATTHEW M Chief Financial Officer | Grant or award · Restricted Stock Units | +33,044 | 33,044 | ||
| 2021-06-02 | WALSH MATTHEW M Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +193,302 | 193,302 | ||
| 2021-06-02 | Merck & Co., Inc. 10% owner | Other disposition | −253,516,000 | 0 |
Page 46 of 46 · 918 trades